Compare CBUS & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBUS | AIRS |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.2M | 122.6M |
| IPO Year | 2017 | 2021 |
| Metric | CBUS | AIRS |
|---|---|---|
| Price | $1.22 | $0.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $12.00 | $1.33 |
| AVG Volume (30 Days) | 108.8K | ★ 1.8M |
| Earning Date | 11-12-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,639,000.00 | ★ $151,818,000.00 |
| Revenue This Year | $39.09 | N/A |
| Revenue Next Year | $107.71 | $0.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.02 | $0.52 |
| 52 Week High | $4.19 | $5.79 |
| Indicator | CBUS | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 45.80 | 33.51 |
| Support Level | N/A | $0.52 |
| Resistance Level | $1.65 | $1.95 |
| Average True Range (ATR) | 0.17 | 0.17 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 42.58 | 11.99 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.